Dalum I, Jensen M R, Gregorius K, Thomasen C M, Elsner H I, Mouritsen S
M&E Biotech A/S, Hørsholm, Denmark.
Mol Immunol. 1997 Nov-Dec;34(16-17):1113-20. doi: 10.1016/s0161-5890(97)00147-8.
Self proteins are handled in the same way as foreign proteins by antigen presenting cells, but because of T-cell tolerance the presentation of self peptides does not normally lead to T cell activation. By providing physically linked T-cell help it is possible to overcome the B cell non-responsiveness toward self antigens. We have shown previously that a very potent antibody response, cross-reactive with a self protein, can be rapidly induced by immunizing with a recombinant immunogen consisting of the self protein with a foreign immunodominant T helper epitope inserted into its sequence (Dalum, I., Jensen, M. R., Hindersson, P., Elsner, H. I. and Mouritsen, S. (1996) J. Immnunol. 157, 4796). In this study we compare this approach for inducing autoantibodies against a self protein with the traditional method of conjugating the self antigen to a foreign carrier protein. The highly conserved self protein ubiquitin with an inserted epitope from ovalbumin (UbiOVA) is used as a model protein and compared to two traditionally conjugated immunogens consisting of ubiquitin chemically conjugated to a peptidic T helper epitope or to ovalbumin. The traditionally conjugated immunogens induce much slower and low titered ubiquitin specific antibody responses than the recombinant construct which also is capable of inducing antibodies directed against a much broader range of potential ubiquitin B cell determinants than the chemically conjugated immunogens. All three constructs are processed by antigen presenting cells and ovalbumin derived T cell epitopes are presented to T helper cells. From these observations it seems likely that the presence of non-shielded autologous B cell determinants on the immunogen is critical for the ability to induce a strong autoantibody response with a diverse fine specificity. Furthermore, the ubiquitin specific antibodies induced by UbiOVA contain higher levels of IgG2a/b relative to IgG1 compared to the conjugates. We therefore speculate that the insertion of a T cell epitope directly into the self antigen could possibly induce an immune response with a different Th1/Th2 balance than a response induced with traditional conjugates.
抗原呈递细胞处理自身蛋白的方式与处理外来蛋白相同,但由于T细胞耐受性,自身肽的呈递通常不会导致T细胞活化。通过提供物理连接的T细胞辅助,可以克服B细胞对自身抗原的无反应性。我们之前已经表明,通过用重组免疫原进行免疫,可以快速诱导出与自身蛋白交叉反应的非常有效的抗体反应,该重组免疫原由自身蛋白组成,其序列中插入了外来免疫显性T辅助表位(Dalum, I., Jensen, M. R., Hindersson, P., Elsner, H. I.和Mouritsen, S. (1996) J. Immnunol. 157, 4796)。在本研究中,我们将这种诱导针对自身蛋白的自身抗体的方法与将自身抗原与外来载体蛋白偶联的传统方法进行了比较。将具有来自卵清蛋白的插入表位的高度保守的自身蛋白泛素(UbiOVA)用作模型蛋白,并与两种传统偶联的免疫原进行比较,这两种免疫原分别是化学偶联了肽性T辅助表位或卵清蛋白的泛素。与重组构建体相比,传统偶联的免疫原诱导泛素特异性抗体反应的速度要慢得多,且滴度较低,重组构建体还能够诱导针对比化学偶联免疫原更广泛的潜在泛素B细胞决定簇的抗体。所有三种构建体都由抗原呈递细胞处理,并且来自卵清蛋白的T细胞表位会呈递给T辅助细胞。从这些观察结果来看,免疫原上存在未被屏蔽的自体B细胞决定簇对于诱导具有多种精细特异性的强烈自身抗体反应的能力至关重要。此外,与偶联物相比,UbiOVA诱导的泛素特异性抗体中IgG2a/b相对于IgG1的水平更高。因此,我们推测将T细胞表位直接插入自身抗原可能会诱导出与传统偶联物诱导的免疫反应具有不同Th1/Th2平衡的免疫反应。